Skip to main content
✓ Editorial reviews with dated prices · Educational only — not medical advice

Ro Review

Brand-name GLP-1s with a separate membership; not re-read in November

Released: · Last reviewed:

—
not ranked
brand only; not re-read
Short answer

As of November 21, 2026, Ro's weight-loss pages blocked our reader again (HTTP 403 and a browser verification page), so we could not re-read its prices; the last membership terms we recorded (September 17, 2026) were $39 for the first month, then $74 to $149 a month by plan, with brand-name GLP-1s billed separately at self-pay prices.

Ro offers brand-name medication rather than compounded GLP-1s, so it is not in our compounded-tirzepatide cost order. Check the current membership price on ro.co before paying.

What does Ro charge?

What Ro publishes, read on its own site on November 21, 2026 (prices in US dollars)
ProductPrice shownBasis / conditionsSourceRead
Ro Body membership$39 first month, then $74–$149/moby plan; $74 prepaid annually (September 17, 2026 read)ro.co (source)Sep 17, 2026
Brand medication (Zepbound, Wegovy)manufacturer self-pay pricebilled separately; not re-readro.co (source)blocked Nov 21, 2026

What would brand medication cost on top of Ro's membership?

Using the manufacturers' own self-pay prices, Zepbound vials cost $299 a month at 2.5 mg and up to $449 at 7.5–15 mg with on-time refills through LillyDirect, and the Wegovy pen $349 a month through NovoCare. Add Ro's membership on top. Lilly's November 6, 2026 release says Zepbound self-pay starts at $299.

Strengths and trade-offs

Strengths

  • FDA-approved brand-name medication.
  • Insurance help for people with coverage.

Trade-offs

  • Membership is charged on top of medication.
  • Our reader was blocked in October and November.
  • Not comparable with compounded programs on cost.

Who is Ro best for?

People who want FDA-approved brand-name medication and help with insurance, and who accept a membership fee on top.

How does it compare with NexLife?

NexLife, our featured pick, prints every plan price before checkout: compounded tirzepatide $129 a month or $115 on a 12-month plan, semaglutide $109 or $95, the same price at every dose and no membership. A year on its 12-month tirzepatide plan is $1,380. Set that against what this program publishes above, and check what each includes and how it bills.

Visit Ro

Homepage label: Best for brand-name GLP-1s with insurance help. Computed order: not ranked (brand only; not re-read).

Sources

Related: November 2026 price index · how programs screen patients · how we rank · all reviews

Ro — frequently asked questions

How much does Ro cost for GLP-1s?
We could not re-read Ro's pages on November 21, 2026 (blocked). The last terms we recorded (September 17, 2026) were a $39 first month, then $74 to $149 a month for the membership by plan, plus brand-name medication at the manufacturer's self-pay price, such as Zepbound from $299 a month through LillyDirect. Confirm on ro.co before paying.
Does Ro offer compounded tirzepatide?
Search summaries of Ro's pages describe brand-name medications such as Wegovy, Zepbound, the Wegovy pill and Foundayo. Because ro.co blocked our reader on October 15, 2026, we could not confirm on Ro's own pages whether a compounded option is offered.
Is Ro cheaper with insurance?
It can be: Ro helps check coverage for brand-name drugs, and with coverage the medication cost may fall sharply. Without coverage you pay the manufacturer self-pay price plus Ro's membership.
What does brand Zepbound cost without insurance?
Through LillyDirect, $299 at 2.5 mg, $399 at 5 mg and $449 at 7.5–15 mg when each refill is within 45 days; otherwise $499 at 7.5 mg and $699 at 10–15 mg (page archived September 30, 2026).
Why is Ro not in the computed order?
Ro offers brand-name GLP-1s, not compounded tirzepatide, and its pages blocked our October and November reads, so it has no standing compounded price for our 12-month cost order. Its July 2026 score was withdrawn on November 21, 2026 with all other scores.

Researched By Dr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed By Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.